Viridian Therapeutics, Inc.(VRDN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VRDN Viridian Therapeutics, Inc.

休市中 07-26 16:00:00 EDT

16.66

+0.32

+1.96%

盘后16.66

+0.000.00%

17:22 EDT

最高17.47	最低16.20	成交量91.59万
今开16.92	昨收16.34	日振幅7.77%
总市值10.63亿	流通市值7.96亿	总股本6,382万
成交额1,521万	换手率1.92%	流通股本4,776万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VRDN","market":"US","secType":"STK","nameCN":"Viridian Therapeutics, Inc.","latestPrice":16.66,"timestamp":1722024000000,"preClose":16.34,"halted":0,"volume":915869,"hourTrading":{"tag":"盘后","latestPrice":16.66,"preClose":16.66,"latestTime":"17:22 EDT","volume":15834,"amount":263800.32,"timestamp":1722028938377},"delay":0,"floatShares":47760152,"shares":63822468,"eps":-4.409268,"marketStatus":"休市中","marketStatusCode":7,"change":0.32,"latestTime":"07-26 16:00:00 EDT","open":16.92,"high":17.47,"low":16.2,"amount":15205857.032194998,"amplitude":0.077723,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.409268,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"adjPreClose":16.34,"preHourTrading":{"tag":"盘前","latestPrice":17.01,"preClose":16.34,"latestTime":"09:29 EDT","volume":810,"amount":13886.631899999998,"timestamp":1722000599999},"postHourTrading":{"tag":"盘后","latestPrice":16.66,"preClose":16.66,"latestTime":"17:22 EDT","volume":15834,"amount":263800.32,"timestamp":1722028938377},"volumeRatio":0.9349126832279909,"impliedVol":0.8774,"impliedVolPercentile":0.6508},"requestUrl":"/m/hq/s/VRDN","defaultTab":"news","newsList":[{"id":"2454409373","title":"Viridian Therapeutics, Inc.盘中异动 快速上涨5.02%报17.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454409373","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454409373?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:35","pubTimestamp":1722000910,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时35分，Viridian Therapeutics, Inc.股票出现波动，股价快速上涨5.02%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Windtree Therapeutics, Inc.、Cel-Sci Corporation、Nutriband Inc C/Wts 涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Cel-Sci Corporation较为活跃，换手率分别为3101.43%、100.20%、31.03%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Cel-Sci Corporation、Promis Neurosciences Inc.，振幅分别为43.16%、39.67%、20.82%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213511aefbb1c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213511aefbb1c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VRDN","LENZ"],"gpt_icon":0},{"id":"2454745158","title":"Viridian Therapeutics, Inc.盘中异动 早盘股价大涨5.88%报16.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454745158","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454745158?lang=zh_cn&edition=full","pubTime":"2024-07-25 21:52","pubTimestamp":1721915532,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日21时52分，Viridian Therapeutics, Inc.股票出现波动，股价急速上涨5.88%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为1067.67%、359.00%、153.53%，振幅较大的相关个股有Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为114.90%、92.06%、50.00%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072521521296820514&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072521521296820514&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRDN","BK4139","LENZ"],"gpt_icon":0},{"id":"2442339513","title":"BUZZ-Viridian 因计划开始眼疾药物的后期试验而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2442339513","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442339513?lang=zh_cn&edition=full","pubTime":"2024-06-11 20:50","pubTimestamp":1718110224,"startTime":"0","endTime":"0","summary":"    6月11日 - ** Viridian Therapeutics   股价盘前上涨6.4%至13美元 ** 该公司计划在8月份开始两项后期研究，测试其治疗中重度甲状腺眼疾患者的实验性药物 ** 预计将于 2026 年上半年获得研究数据 ** TED是一种自身免疫性眼病，会导致眼周组织炎症和损伤。** 截至上一交易日收盘，股价年累计下跌约 44","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VRDN","BUZZ"],"gpt_icon":0},{"id":"2433447267","title":"Viridian Therapeutics Inc    预计每股亏损 1.10 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433447267","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433447267?lang=zh_cn&edition=full","pubTime":"2024-05-06 22:15","pubTimestamp":1715004917,"startTime":"0","endTime":"0","summary":"   * Viridian Therapeutics Inc    将于5月8日公布截至2024年3月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，11位分析师的平均预期显示，这家总部位于马萨诸塞州沃尔瑟姆的公司的营收将从去年同期的9.8万美元下降27.4%，至7.118万美元。* LSEG 分析师对 Viridian Therapeutics Inc 的平均预期是每股亏损 1.10 美元。* 华尔街对 Viridian Therapeutics Inc 的 12 个月目标价中位数为 37.00 美元，高于其上次收盘价 15.40 美元。5月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRDN","LENZ"],"gpt_icon":0},{"id":"2421025459","title":"BUZZ-竞争对手中外制药的数据不尽如人意，Immunovant 和 Argenx 的业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2421025459","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421025459?lang=zh_cn&edition=full","pubTime":"2024-03-22 00:04","pubTimestamp":1711037051,"startTime":"0","endTime":"0","summary":"    3月21日 - ** 在日本中外制药公司  报告了其自身免疫性疾病药物satralizumab的后期数据后，Immunovant  的股价上涨2.5%至32.36美元，在美国上市的Argenx  的股价上涨12.3%至401美元。** 券商 Stifel 表示，由于该药物之前的研究数据令人印象深刻，因此该数据一直是 ARGX 和 IMVT 的主要障碍。** ARGX公司的Vyvgrat已被批准用于治疗这种疾病，而IMVT公司的实验性疗法正处于后期研究阶段。** Viridian Therapeutics    和 Tourmaline Bio    的股价分别下跌了 38.8% 和 38.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","IMVT","BK4139","TRML","VRDN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.viridiantherapeutics.com","stockEarnings":[{"period":"1week","weight":0.1513},{"period":"1month","weight":0.3534},{"period":"3month","weight":0.2935},{"period":"6month","weight":-0.1624},{"period":"1year","weight":-0.0836},{"period":"ytd","weight":-0.2351}],"compareEarnings":[{"period":"1week","weight":-0.0083},{"period":"1month","weight":-0.002},{"period":"3month","weight":0.0712},{"period":"6month","weight":0.117},{"period":"1year","weight":0.2032},{"period":"ytd","weight":0.1454}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Viridian Therapeutics, Inc.于2014年6月17日在特拉华州成立，该公司是一家生物制药公司，专注于研究和开发针对严重和罕见疾病的潜在最佳药物。该公司瞄准的是竞争不激烈的疾病领域，在这些领域，已上市的疗法往往为提高疗效、安全性或给药便利性留出空间。该公司认为，第一代药物很少代表最佳解决方案，特别是在罕见病领域，而且有潜力开发差异化、同类最佳的药物，从而改善患者的治疗效果、减少副作用、提高生活质量、扩大市场准入和加强市场竞争。该公司正在开发三种候选产品：VRDN-001、VRDN-002和VRDN-003，这些产品正在开发中，用于静脉注射或皮下注射，以治疗患有甲状腺眼病（TED）的患者。该公司最先进的项目VRDN-001是一种靶向IGF-1R的差异化人源化单克隆抗体，用于治疗TED。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.315821},{"month":2,"riseRate":0.2,"avgChangeRate":-0.068987},{"month":3,"riseRate":0.3,"avgChangeRate":-0.074769},{"month":4,"riseRate":0.6,"avgChangeRate":0.030899},{"month":5,"riseRate":0.2,"avgChangeRate":-0.023661},{"month":6,"riseRate":0.5,"avgChangeRate":0.006153},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.013421},{"month":8,"riseRate":0.1,"avgChangeRate":-0.091226},{"month":9,"riseRate":0.3,"avgChangeRate":-0.087401},{"month":10,"riseRate":0.2,"avgChangeRate":-0.053633},{"month":11,"riseRate":0.6,"avgChangeRate":0.153546},{"month":12,"riseRate":0.4,"avgChangeRate":-0.070141}],"exchange":"NASDAQ","name":"Viridian Therapeutics, Inc.","nameEN":"Viridian Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Viridian Therapeutics, Inc.(VRDN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Viridian Therapeutics, Inc.(VRDN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Viridian Therapeutics, Inc.,VRDN,Viridian Therapeutics, Inc.股票,Viridian Therapeutics, Inc.股票老虎,Viridian Therapeutics, Inc.股票老虎国际,Viridian Therapeutics, Inc.行情,Viridian Therapeutics, Inc.股票行情,Viridian Therapeutics, Inc.股价,Viridian Therapeutics, Inc.股市,Viridian Therapeutics, Inc.股票价格,Viridian Therapeutics, Inc.股票交易,Viridian Therapeutics, Inc.股票购买,Viridian Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Viridian Therapeutics, Inc.(VRDN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Viridian Therapeutics, Inc.(VRDN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}